SCHEMBL7904472

SCHEMBL7904472

C[C@@H](C(=O)O)N(C)C(=O)c1cc(C(F)(F)F)cc([N+](=O)[O-])c1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
MAPT P10636 4/20 0.43
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
CYP3A4 P08684 3/20 0.40
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HIF1A Q16665 1/20 0.40
TXNRD1 Q16881 1/20 0.40
TXNRD3 Q86VQ6 1/20 0.40
TXNRD2 Q9NNW7 1/20 0.40
HPD P32754 1/20 0.39
MAPK1 P28482 3/20 0.39
POLB P06746 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MEN1 O00255 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7904468 1.00 ALDH1A1 (0.49) ALDH1A1MAPTLMNAHTTCYP3A4
SCHEMBL7905592 0.83 ALDH1A1 (0.40) ALDH1A1HPGDP2RX1
SCHEMBL7905588 0.83 ALDH1A1 (0.40) ALDH1A1HPGDP2RX1
SCHEMBL7903545 0.78 ALDH1A1 (0.64) ALDH1A1MAPTLMNAHTTCYP3A4
SCHEMBL9311399 0.78 ALDH1A1 (0.50) ALDH1A1MAPTLMNAHTTCYP3A4
SCHEMBL9311405 0.78 ALDH1A1 (0.50) ALDH1A1MAPTLMNAHTTCYP3A4
SCHEMBL7904464 0.72 ALDH1A1 (0.49) ALDH1A1MAPTLMNAHTTCYP3A4
SCHEMBL12329596 0.72 ALDH1A1 (0.72) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL28575302 0.72 ATM (0.43) ALDH1A1HTTTDP1
SCHEMBL9015339 0.72 ALDH1A1 (0.82) ALDH1A1MAPTLMNAHTTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed